NFKB1 and cancer: M1‐Exos stimulate naïve macrophages to increase proinflammatory cytokines release through the NF‐κB pathway and increase the activities of caspase‐3 in cancer cells. Paclitaxel‐loaded M1‐Exos displayed robust cytotoxicity against tumour cells